Skip to main content
. 2020 Apr 16;15(4):e0231716. doi: 10.1371/journal.pone.0231716

Fig 4. Enriched variants provide high on-target efficacy and reduced cleavage at an off-target locus in T-cells.

Fig 4

(A) Indel fraction at the on-target locus measured in a dose response of four mutant proteins and the wildtype SpCas9. (B) Indel fraction at a single off-target locus measured in a dose response of four mutant proteins and the wildtype SpCas9. Experiments were performed in duplicate, and the value shown is the average of the two replicates.